Division of Hematology and Oncology

July 17, 2014

VICC’s Abramson lands breast cancer clinical research award

Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF).

By VUMC News and Communications
February 27, 2014

Probing the pathogenesis of leukemia

A new mouse model reveals gene clusters important in a treatment-resistant form of leukemia.

By Leigh MacMillan
January 10, 2014

Kudos: Read about faculty and staff awards and achievements

Read about faculty and staff awards and achievements in the latest edition of “Kudos.”

By VUMC News and Communications
October 10, 2013

Probing mutant EGF receptor regulation

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.

By Leigh MacMillan
July 11, 2013

Lovly lands Damon Runyon cancer research award

Christine Lovly, M.D., Ph.D., assistant professor of Medicine, has received the 2013 Damon Runyon Clinical Investigator Award, which supports young physician-scientists conducting patient-oriented cancer research.

By VUMC News and Communications
May 30, 2013

Berlin earns stomach cancer foundation award

Jordan Berlin, M.D., professor of Medicine and Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, has received the Tree of Life award from Debbie’s Dream Foundation: Curing Stomach Cancer (DDF).

By VUMC News and Communications
April 11, 2013

Leukemia culprit’s cellular actions

Overexpression of a gene that is a common culprit in leukemia induces stem cell-like features in T cells, which may enable the cells to become cancerous.
By Leigh MacMillan
March 28, 2013

Foundation lauds graduate student’s melanoma research

Katherine Hutchinson, a third-year graduate student in Cancer Biology at Vanderbilt University, has won a $10,000 Research Scholar Award from the Joanna M. Nicolay Melanoma Foundation.
By Bill Snyder
December 7, 2012

Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers

Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators.
By VUMC News and Communications
June 11, 2012

Vanderbilt identifies genes linked to breast cancer chemo resistance

A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
By VUMC News and Communications
1 … 12 13 14 15